Evidence map›Paper›PMID 18414388›Full record

ArticleBritish journal of pharmacology2008

Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk.

V Sibilia, F Pagani, G Rindi, N Lattuada, D Rapetti, V De Luca, N Campanini, I Bulgarelli, V Locatelli, F Guidobono and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Potentiality of ghrelin as antioxidant and protective agent.Redox report : communications in free radical research · 2021
    Pooled it
  2. Effect ofFoods (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Diligustilide releases HInflammopharmacology · 2018
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ghrelin and oxidative stress in gastrointestinal tract.Journal of clinical biochemistry and nutrition · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

V SibiliaDepartment of Pharmacology, Chemotherapy and Medical Toxicology, University of Milano, Milan, Italy. valeria.sibilia@unimi.it
F Pagani
G Rindi
N Lattuada
D Rapetti
V De Luca
N Campanini
I Bulgarelli
V Locatelli
F Guidobono
C Netti
University of Milan · ITUniversity of Milano-Bicocca · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeGhrelin, a gut-brain peptide, is considered a gastroprotective factor in gastric mucosa. We investigated the role of prostaglandins (PG) and the possible interplay between PGs and nitric oxide (NO) in ghrelin gastroprotection against ethanol (EtOH)-induced gastric lesions. EXPERIMENTAL APPROACH: We examined the effects of (1) central ghrelin (4 mug per rat) injection on PGE(2) accumulation in normal or EtOH-lesioned gastric mucosa, (2) pretreatment with indomethacin (10 mg kg(-1), p.o.), a non-selective cyclooxygenase (COX) inhibitor, and with a selective COX-1, SC560 (5 mg kg(-1), p.o.) or COX-2 inhibitor, celecoxib (3.5 mg kg(-1), p.o.) on ghrelin gastroprotection against 50% EtOH (1 mL per rat)-induced gastric lesions, (3) the NO synthase inhibitor, L-NAME (70 mg kg(-1), s.c), on gastric PGE(2) content in ghrelin-treated rats and (4) central ghrelin on the expression of constitutive and inducible NOS and COX mRNA and on the localization of the immunoreactivity for COX-2 in the gastric mucosa exposed to EtOH. KEY

resultsGhrelin increased PGE(2) in normal mucosa, whereas, it reversed the EtOH-induced PGE(2) surge. Ghrelin had no effect on mucosal COX-1 expression but reduced the EtOH-induced increase in COX-2 expression and immunoreactivity. Indomethacin and SC560, but not celecoxib, removed ghrelin gastroprotection. L-NAME prevented the PGE(2) surge induced by ghrelin and, like indomethacin, reduced EtOH-induced PGE(2) increase. Ghrelin enhanced eNOS expression and reduced iNOS mRNA. CONCLUSIONS AND IMPLICATIONS: This study shows that COX-1-derived PGs are mainly involved in ghrelin gastroprotection and that the constitutive-derived NO together with PGE(2) are involved in ghrelin gastroprotective activity.

Indexed as

AnimalsCyclooxygenase 1Cyclooxygenase 2DinoprostoneEthanolGastric MucosaGene Expression Regulation, EnzymologicGhrelinMaleNitric OxideNitric Oxide Synthase Type IINitric Oxide Synthase Type IIIRatsRats, Sprague-DawleyRNA, MessengerStomach UlcerCyclooxygenase 1Cyclooxygenase 2DinoprostoneEthanolGhrelinNitric OxideNitric Oxide Synthase Type IINitric Oxide Synthase Type IIIRNA, Messenger

Identifiers

PMID18414388
PMCPMC2439519
OpenAlexW2066577165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.